Early tumor shrinkage in metastatic colorectal cancer: Retrospective analysis from an irinotecan‐based randomized first‐line trial

Early tumor shrinkage (ETS) has been highlighted as a favorable prognostic factor related to progression‐free survival (PFS) and overall survival (OS) in cytotoxic treatment of metastatic colorectal cancer. Data from a randomized phase III study comparing infusional 5‐fluorouracil plus irinotecan (F...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Sci
Autors principals: Giessen, Clemens, Laubender, Ruediger P., Fischer von Weikersthal, Ludwig, Schalhorn, Andreas, Modest, Dominik P., Stintzing, Sebastian, Haas, Michael, Mansmann, Ulrich R., Heinemann, Volker
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2013
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7657245/
https://ncbi.nlm.nih.gov/pubmed/23480146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12148
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars